Although people have greater access to personalized drugs and tests than ever before, a survey by GenomeWeb and the PMC shows public awareness isn't improving.
The companies plan to develop a pan-cancer CDx to measure microsatellite instability and CDx tests for tumor mutational burden and other novel biomarkers of response.
While a randomized-controlled trial is underway, Genomind hopes data from a new case-control study will convince insurers its PGx test can reduce healthcare utilization costs.
Using a protocol developed at the University of Oxford, the researchers hope that nanopore sequencing can aid diagnosis and drug resistance profiling in remote areas.
Using a protocol developed at the University of Oxford, the researchers hope that nanopore sequencing can aid diagnosis and drug resistance profiling in remote areas.
Using a protocol developed at the University of Oxford, the researchers hope that nanopore sequencing can aid diagnosis and drug resistance profiling in remote areas.
Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.
The introduction of digital pathology has opened the door to countless new possibilities. Whole Slide Imaging, computational image analysis and automated workflows are redefining pathology and shaping the future of cancer care. Join us as we review new applications in digital pathology which provide the necessary tools pathologists need in order to meet the growing demands of modern pathology.
The BD Rhapsody Single-Cell Analysis System empowers and streamlines single-cell research with a complete system of tools, including reagents and analysis software, that work together to meet neuroscience experimental needs. Neuroscientists’ ability to identify and characterize individual cells in the nervous system opens the door to finding pathogenic cells, regenerative cells, and pathways that drug manufacturers can exploit for the discovery of therapeutics for neurodegenerative disease.
As the field of therapeutic antibody research expands, scientists face a growing need for software that enables them to efficiently and accurately analyze their data. Highly functional bioinformatics software solutions significantly reduce the need to manually curate sequence data or convert it into different formats for sharing and archiving. Unfortunately, there are currently few specialist antibody screening and analysis platforms that can be quickly configured to meet the highly custom needs of specialized therapeutic antibody discovery organizations.
